Registration and abstract submission is now open for the 4th Correlates of Protection for Next Generation Influenza Vaccines Meeting in Vienna this fall!
https://t.co/tJ0bxbc5Ak
een derde van de Nederlandse wetenschappers in een peiling in Nederland merkt de effecten van Trump. Bij ons 2 projecten van @rorydevries acuut gestopt, en - sinds deze peiling- tien andere vermoedelijk ook. Onbetrouwbare partner geworden helaas https://t.co/juq5ZXFJnm
GVN member Dr. @rorydevries' study examines COVID-19 vaccine immunogenicity and safety in pancreatic cancer patients. This research offers key insights into vaccine responses, aiding future treatment strategies. Read more: https://t.co/8lhigBRNqD #ErasmusMC
@ajboekestijn@mkeulemans Dat gebeurt, in finland en in nl. Fi is mensen aan het vaccineren die met geinfecteerde dieren werken. Ze onderzoeken daarbij hoe goed de vaccins immuniseren, ism ons lab. Hetzelfde is in voorbereiding in nederland @rorydevries. Ook onderzoek basisimmuniteit in de bevolking
@DURABLE_EU partner @rorydevries at #erasmusmc developed and validated an organoid-based neutralization assay that holds promise for further characterization of correlates of protection against HRSV disease. Read more here: https://t.co/2Xkr8roAMW
@hk_nien@MarionKoopmans We think it is the limited in-host replication in the host after vaccination. MVA replicates a single round without the production of progeny virus, whereas the more “classical” vaccinia vaccines established a productive infection😀
waning of antibodies to vaccinia and mpox virus neutralising antibodies 1 year post MVA vaccination. Important to study in the context of questions on vaccine efficacy https://t.co/7kjoL65Sli
T cells enthusiasts we are hiring! Come to work with us on new Infectious diseases. Looking for a postdoc and want to know more? Apply!
https://t.co/D0bzIVSJd3
resurgence of clade II mpox in the US. A perfectly preventable disease, that emerged globally in 2022 and despite its relatively low transmissibility was not stopped. This is how prepared we are people. https://t.co/csuyWZ7QJk
Ongelooflijk verheugd over het nieuws dat @ZonMw ons project gericht op pathogenese van long-COVID 🦠 vanuit immunologisch/virologisch perspectief gaat subsidiëren! Met het hele team @ErasmusMC gaan we hier zsm onze schouders onder zetten!
@svscarpino@thilogross@manlius84@DirkBrockmann@sciencecohen I’m not aware of any evidence for this. The lymphopenia after COVID is quite different from what’s observed after measles, although it definitely warrants further investigation.